Search Within

Mary Ellen Moynahan

Formats
  1. Journal Article (56)
  2. Meeting Abstract (46)
  3. Conference Paper (2)
  4. Book Section (1)
Groups
  1. Breast Medicine Service (105)
  2. Department of Medicine (105)
  3. Solid Tumor Oncology Division (105)
  4. Survivorship Research (59)
  5. GSK Faculty (52)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)

More Groups

People
  1. Clifford Hudis (54)
  2. Larry Norton (38)
  3. Maria Jasin (30)
  4. Andrew Seidman (28)
  5. Teresa Gilewski (26)
  6. Gabriella D'Andrea-Carlino (25)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (2)
  4. 2017 (2)
  5. 2016 (9)
  6. 2015 (10)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Cancer Research (14)
  3. Breast Cancer Research and Treatment (12)
  4. Clinical Cancer Research (8)
  5. Proceedings of the National Academy of Sciences of the United States of America (4)
  6. Clinical Breast Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. American Association for Cancer Research (23)
  3. Springer (12)
  4. Elsevier Inc. (11)
  5. Nature Publishing Group (5)
  6. Cell Press (4)

More Publishers

Results (105)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with Metastatic breast cancer
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Robson, M.; Goldfarb, S.; Drullinsky, P.; Sugarman, S.; Wasserheit Leiblich, C.; Fasano, J.; more...
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to cisplatin and poly (ADP-ribose) polymerase inhibition
    Meeting Abstract

    Cavallo, F.; Graziani, G.; Antinozzi, C.; Feldman, D. R.; Houldsworth, J.; Bosl, G. J.; Chaganti, R. S. K.; Moynahan, M. E.; Jasin, M.; Barchi, M.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer
    Journal Article

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Moynahan, M. E.; Lake, D.; Forero, A.; Wright, G. S.; Hackney, M. H.; Clawson, A.; Norton, L.; more...
    Clinical Breast Cancer (2013)

    Fulltext@MSK | Save
  • Double-strand break repair by homologous recombination in primary mouse somatic cells requires BRCA1 but not the ATM kinase
    Journal Article

    Kass, E. M.; Helgadottir, H. R.; Chen, C. C.; Barbera, M.; Wang, R.; Westermark, U. K.; Ludwig, T.; Moynahan, M. E.; Jasin, M.
    Proceedings of the National Academy of Sciences of the United States of America (2013)

    Fulltext@MSK | Save
  • Inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) to increase radiosensitivity of human pancreatic cancer (PAC) cell lines proficient in homology-directed repair (HDR)
    Meeting Abstract

    Lowery, M. A.; Vanoli, F.; Yu, K. H.; Jasin, M.; O'Reilly, E. M.; Moynahan, M. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • DNA damage and repair in mammary gland development
    Meeting Abstract

    Kass, E. M.; Helgadottir, H.; Moynahan, M. E.; Jasin, M.
    Cancer Research (2012)

    Fulltext@MSK | Save